Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Issue: Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue
Abstract: A formulation for preparing Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords: formulation, dapsone, oral suspension, leprosy, pneumocystis pneumonia, dermatitis herpetiformis
Related Categories: DERMATOLOGY, FORMULATIONS, INFECTIOUS DISEASE, RESPIRATION/LUNG/BREATHING
Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4388
Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products